Monday, October 26, 2026 · Daily editionET --:--:--

By invitation only

A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer

NCT06906952 · Nanchang University · Updated 30 Jan 2026

What is being tested
robotic natural orifice specimen extraction surgery; robotic transabdominal specimen extraction surgery
For
Natural Orifice Specimen Extraction Surgery; Robotic Surgery; Short-term Outcomes
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 100 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 Oct 2024, ends 28 Feb 2027. Registered 2 April 2025.
Results
None posted yet.

In the researchers' words

This study aimed to compare the short-term efficacy of robotic radical resection of high rectal cancer and sigmoid colon cancer (NOSES-IV) with transrectal resection specimens and traditional robotic surgery in the treatment of high rectal cancer and sigmoid colon cancer. At the same time, the safety and advantages of robotic radical resection of high rectal cancer and sigmoid colon cancer (NOSES-IV) with transrectal resection specimens and traditional robotic surgery in the treatment of high rectal cancer and sigmoid colon cancer were compared.
ClinicalTrials.gov, NCT06906952

Sites

  • the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000Nanchang, China